COURTNEY RAY: Open Payments
NPI 1538932280 · SAN LUIS OBISPO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,148 in 187 payments from 16 companies in 2025. Trend: 2023 $39 · 2024 $3,901 · 2025 $4,148
Food & beverage: $4,147Education: $1
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 74 | $1,529 |
| Amgen Inc. | 39 | $880 |
| Janssen Biotech, Inc. | 34 | $444 |
| UCB, Inc. | 10 | $322 |
| AstraZeneca Pharmaceuticals LP | 6 | $156 |
| Janssen Scientific Affairs, LLC | 1 | $147 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Novartis Pharmaceuticals Corporation | 5 | $110 |
| E.R. Squibb & Sons, L.L.C. | 4 | $101 |
| Genentech USA, Inc. | 3 | $93 |
Products named: RINVOQ, SKYRIZI, TREMFYA, Bimzelx, OTEZLA, EVENITY, KRYSTEXXA, UPLIZNA.
Industry payments across CA — which companies pay providers there.
